Keros Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-16.0M | $-16.3M | $271.0K | $59.0K |
| FY2020 | $-36.9M | $-37.2M | $294.0K | $4.1M |
| FY2021 | $-62.1M | $-63.2M | $1.0M | $11.7M |
| FY2022 | $-70.1M | $-71.3M | $1.2M | $18.7M |
| FY2023 | $-124.5M | $-127.0M | $2.5M | $28.8M |
| FY2024 | $-160.9M | $-162.8M | $1.9M | $34.9M |
| FY2025 | $107.5M | $106.0M | $1.6M | $28.7M |